JP5037496B2 - １型糖尿病用の完全自動制御システム - Google Patents

１型糖尿病用の完全自動制御システム Download PDF

Info

Publication number
JP5037496B2
JP5037496B2 JP2008511449A JP2008511449A JP5037496B2 JP 5037496 B2 JP5037496 B2 JP 5037496B2 JP 2008511449 A JP2008511449 A JP 2008511449A JP 2008511449 A JP2008511449 A JP 2008511449A JP 5037496 B2 JP5037496 B2 JP 5037496B2
Authority
JP
Japan
Prior art keywords
subject
insulin
blood glucose
glucose level
control signal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008511449A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008545454A5 (https=
JP2008545454A (ja
Inventor
ダミアノ，エドワード
エルハティーブ，フィラス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Original Assignee
Boston University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston University filed Critical Boston University
Publication of JP2008545454A publication Critical patent/JP2008545454A/ja
Publication of JP2008545454A5 publication Critical patent/JP2008545454A5/ja
Application granted granted Critical
Publication of JP5037496B2 publication Critical patent/JP5037496B2/ja
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Databases & Information Systems (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Business, Economics & Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Business, Economics & Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
JP2008511449A 2005-05-13 2006-05-15 １型糖尿病用の完全自動制御システム Active JP5037496B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US68112805P 2005-05-13 2005-05-13
US60/681,128 2005-05-13
US73556805P 2005-11-10 2005-11-10
US60/735,568 2005-11-10
PCT/US2006/018620 WO2006124716A2 (en) 2005-05-13 2006-05-15 Fully automated control system for type 1 diabetes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011275281A Division JP5389147B2 (ja) 2005-05-13 2011-12-16 １型糖尿病用の完全自動制御システム

Publications (3)

Publication Number Publication Date
JP2008545454A JP2008545454A (ja) 2008-12-18
JP2008545454A5 JP2008545454A5 (https=) 2009-09-03
JP5037496B2 true JP5037496B2 (ja) 2012-09-26

Family

ID=37431958

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008511449A Active JP5037496B2 (ja) 2005-05-13 2006-05-15 １型糖尿病用の完全自動制御システム
JP2011275281A Active JP5389147B2 (ja) 2005-05-13 2011-12-16 １型糖尿病用の完全自動制御システム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011275281A Active JP5389147B2 (ja) 2005-05-13 2011-12-16 １型糖尿病用の完全自動制御システム

Country Status (5)

Country Link
US (2) US7806854B2 (https=)
EP (1) EP1881786B1 (https=)
JP (2) JP5037496B2 (https=)
CA (1) CA2612714C (https=)
WO (1) WO2006124716A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010531678A (ja) * 2007-06-21 2010-09-30 ユニバーシティ オブ バージニア パテント ファウンデーション Ｌｑｇ人工膵臓制御システム及び関連方法

Families Citing this family (257)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655618B2 (en) * 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
CA2509755A1 (en) 2002-12-27 2004-07-22 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
WO2005089103A2 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
CA3090413C (en) 2004-06-04 2023-10-10 Abbott Diabetes Care Inc. Glucose monitoring and graphical representations in a data management system
US7814838B2 (en) * 2004-06-28 2010-10-19 Automotive Systems, Laboratory, Inc. Gas generating system
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US8956291B2 (en) * 2005-02-22 2015-02-17 Admetsys Corporation Balanced physiological monitoring and treatment system
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
WO2006124716A2 (en) * 2005-05-13 2006-11-23 Trustees Of Boston University Fully automated control system for type 1 diabetes
CN102440785A (zh) 2005-08-31 2012-05-09 弗吉尼亚大学专利基金委员会 传感器信号处理方法及传感器信号处理装置
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US9339217B2 (en) 2011-11-25 2016-05-17 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US8224415B2 (en) 2009-01-29 2012-07-17 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US8473022B2 (en) 2008-01-31 2013-06-25 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US9326709B2 (en) 2010-03-10 2016-05-03 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
US7653425B2 (en) 2006-08-09 2010-01-26 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8374668B1 (en) 2007-10-23 2013-02-12 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US9392969B2 (en) * 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US7618369B2 (en) 2006-10-02 2009-11-17 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US7630748B2 (en) 2006-10-25 2009-12-08 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8478557B2 (en) 2009-07-31 2013-07-02 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US8140312B2 (en) 2007-05-14 2012-03-20 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US20110054391A1 (en) * 2006-07-28 2011-03-03 Ward W Kenneth Analyte sensing and response system
AU2007308804A1 (en) 2006-10-26 2008-05-02 Abbott Diabetes Care, Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US10154804B2 (en) 2007-01-31 2018-12-18 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
WO2008099356A2 (en) * 2007-02-15 2008-08-21 Koninklijke Philips Electronics N.V. Drug delivery device
US8121857B2 (en) 2007-02-15 2012-02-21 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US20080199894A1 (en) 2007-02-15 2008-08-21 Abbott Diabetes Care, Inc. Device and method for automatic data acquisition and/or detection
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8140142B2 (en) 2007-04-14 2012-03-20 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9204827B2 (en) 2007-04-14 2015-12-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US7768387B2 (en) 2007-04-14 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
WO2008130898A1 (en) 2007-04-14 2008-10-30 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
ES2784736T3 (es) 2007-04-14 2020-09-30 Abbott Diabetes Care Inc Procedimiento y aparato para proporcionar el procesamiento y control de datos en un sistema de comunicación médica
ES2817503T3 (es) 2007-04-14 2021-04-07 Abbott Diabetes Care Inc Procedimiento y aparato para proporcionar el procesamiento y control de datos en un sistema de comunicación médica
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8103471B2 (en) 2007-05-14 2012-01-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8239166B2 (en) 2007-05-14 2012-08-07 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8600681B2 (en) 2007-05-14 2013-12-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9125548B2 (en) 2007-05-14 2015-09-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10002233B2 (en) 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8560038B2 (en) 2007-05-14 2013-10-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8260558B2 (en) 2007-05-14 2012-09-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US7996158B2 (en) 2007-05-14 2011-08-09 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8444560B2 (en) 2007-05-14 2013-05-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8417311B2 (en) 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7751907B2 (en) 2007-05-24 2010-07-06 Smiths Medical Asd, Inc. Expert system for insulin pump therapy
US8221345B2 (en) 2007-05-30 2012-07-17 Smiths Medical Asd, Inc. Insulin pump based expert system
CA2690742C (en) 2007-06-21 2018-05-15 Abbott Diabetes Care Inc. Health management devices and methods
CN103251414B (zh) 2007-06-21 2017-05-24 雅培糖尿病护理公司 用于分析物水平的检测的设备
US7768386B2 (en) 2007-07-31 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
EP4159114B1 (en) * 2007-10-09 2024-04-10 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
WO2009049252A1 (en) 2007-10-10 2009-04-16 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US8216138B1 (en) 2007-10-23 2012-07-10 Abbott Diabetes Care Inc. Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
US8409093B2 (en) 2007-10-23 2013-04-02 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US20090164239A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
EP2093685A1 (en) 2008-02-21 2009-08-26 F.Hoffmann-La Roche Ag Drug administration device having a bolus administration profile controller
WO2009115948A1 (en) * 2008-03-17 2009-09-24 Philips Intellectual Property & Standards Gmbh A closed loop system for automatically controlling a physiological variable of a patient
US7826382B2 (en) 2008-05-30 2010-11-02 Abbott Diabetes Care Inc. Close proximity communication device and methods
WO2010011805A1 (en) * 2008-07-24 2010-01-28 Admetsys Corporation Device and method for automatically sampling and measuring blood analytes
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US9943644B2 (en) 2008-08-31 2018-04-17 Abbott Diabetes Care Inc. Closed loop control with reference measurement and methods thereof
US8734422B2 (en) 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
US20100057040A1 (en) 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Robust Closed Loop Control And Methods
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
US8986208B2 (en) 2008-09-30 2015-03-24 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US9149220B2 (en) 2011-04-15 2015-10-06 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US9326707B2 (en) 2008-11-10 2016-05-03 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
BRPI1008849B8 (pt) 2009-02-04 2021-06-22 Sanofi Aventis Deutschland dispositivo médico e método para controle glicêmico
WO2010089307A1 (en) 2009-02-04 2010-08-12 Sanofi-Aventis Deutschland Gmbh Medical system and method for providing information for glycemic control
FR2942387A1 (fr) 2009-02-23 2010-08-27 Ecole Superieure Electricite Systeme de regulation du glucose sanguin d'un sujet vivant diabetique et produit programme d'ordinateur correspondant.
EP2413781B1 (en) * 2009-03-31 2019-07-24 Abbott Diabetes Care Inc. Overnight closed-loop insulin delivery with model predictive control and glucose measurement error model
WO2010121084A1 (en) 2009-04-15 2010-10-21 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
WO2010121229A1 (en) 2009-04-16 2010-10-21 Abbott Diabetes Care Inc. Analyte sensor calibration management
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
EP2425209A4 (en) 2009-04-29 2013-01-09 Abbott Diabetes Care Inc METHOD AND SYSTEM FOR REAL-TIME CALIBRATION OF AN ANALYTICAL SENSOR WITH RETROACTIVE FILLING
US8368556B2 (en) 2009-04-29 2013-02-05 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
EP2432377A1 (en) 2009-05-22 2012-03-28 Abbott Diabetes Care, Inc. Usability features for integrated insulin delivery system
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
EP3284494A1 (en) 2009-07-30 2018-02-21 Tandem Diabetes Care, Inc. Portable infusion pump system
EP4070728A1 (en) 2009-08-31 2022-10-12 Abbott Diabetes Care, Inc. Displays for a medical device
EP2473963A4 (en) 2009-08-31 2014-01-08 Abbott Diabetes Care Inc MEDICAL DEVICES AND METHOD
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
EP2473098A4 (en) 2009-08-31 2014-04-09 Abbott Diabetes Care Inc ANALYTICAL SIGNAL PROCESSING APPARATUS AND METHOD
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9242039B2 (en) 2009-09-29 2016-01-26 Admetsys Corporation System and method for differentiating containers in medication delivery
CN102667787A (zh) 2009-09-30 2012-09-12 莫尔研究应用有限公司 管理胰岛素输注的监视装置
WO2011041531A1 (en) 2009-09-30 2011-04-07 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
EP2494323A4 (en) 2009-10-30 2014-07-16 Abbott Diabetes Care Inc METHOD AND DEVICE FOR DETECTING UNNORMAL HYPOGLYKEMIC VALUES
US8882701B2 (en) 2009-12-04 2014-11-11 Smiths Medical Asd, Inc. Advanced step therapy delivery for an ambulatory infusion pump and system
US8762070B2 (en) * 2010-02-11 2014-06-24 Regents Of The University Of California Systems, devices and methods to deliver biological factors or drugs to a subject
DK3622883T3 (da) 2010-03-24 2021-07-19 Abbott Diabetes Care Inc Indførerer til medicinsk indretning og fremgangsmåder til at indføre og anvende medicinske indretninger
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US8945094B2 (en) * 2010-09-08 2015-02-03 Honeywell International Inc. Apparatus and method for medication delivery using single input-single output (SISO) model predictive control
WO2012048168A2 (en) 2010-10-07 2012-04-12 Abbott Diabetes Care Inc. Analyte monitoring devices and methods
WO2012051344A2 (en) * 2010-10-12 2012-04-19 Regents Of The University Of California, The Maintaining multiple defined physiological zones using model predictive control
ES2755497T3 (es) * 2010-10-31 2020-04-22 Univ Boston Sistema de control de glucosa en sangre
CA3277222A1 (en) 2011-02-28 2025-10-30 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
EP3556285B2 (en) 2011-06-16 2026-03-18 Abbott Diabetes Care, Inc. Temperature-compensated analyte monitoring devices, systems, and methods thereof
WO2013066849A1 (en) 2011-10-31 2013-05-10 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
EP3677182B1 (en) 2011-11-07 2022-05-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
FI3300658T3 (fi) 2011-12-11 2024-03-01 Abbott Diabetes Care Inc Analyyttianturimenetelmiä
WO2013113391A2 (en) * 2012-02-02 2013-08-08 Brainlab Ag Method for determining an infusion parameter
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9757510B2 (en) * 2012-06-29 2017-09-12 Animas Corporation Method and system to handle manual boluses or meal events for closed-loop controllers
EP2890297B1 (en) 2012-08-30 2018-04-11 Abbott Diabetes Care, Inc. Dropout detection in continuous analyte monitoring data during data excursions
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9907492B2 (en) 2012-09-26 2018-03-06 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US9833191B2 (en) 2012-11-07 2017-12-05 Bigfoot Biomedical, Inc. Computer-based diabetes management
US9907909B2 (en) 2012-12-20 2018-03-06 Animas Corporation Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
KR102212020B1 (ko) 2013-01-14 2021-02-05 더 리전트 오브 더 유니버시티 오브 캘리포니아 제1형 당뇨병 응용을 위한 인공 췌장에 대한 모델 예측 제어 문제에서의 일주기 목표-구역 조절
US9940441B2 (en) 2013-03-13 2018-04-10 Tandem Diabetes Care, Inc. System and method for maximum insulin pump bolus override
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US10076285B2 (en) 2013-03-15 2018-09-18 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
EP2973095B1 (en) * 2013-03-15 2018-05-09 Animas Corporation Insulin time-action model
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
EP3041528A4 (en) 2013-09-06 2017-04-26 Tandem Diabetes Care, Inc. System and method for mitigating risk in automated medicament dosing
WO2015061693A1 (en) 2013-10-24 2015-04-30 Trustees Of Boston University Infusion system employing an infusion set for preventing mischanneling of multiple medicaments
US10569015B2 (en) 2013-12-02 2020-02-25 Bigfoot Biomedical, Inc. Infusion pump system and method
US9750877B2 (en) 2013-12-11 2017-09-05 Medtronic Minimed, Inc. Predicted time to assess and/or control a glycemic state
US9750878B2 (en) * 2013-12-11 2017-09-05 Medtronic Minimed, Inc. Closed-loop control of glucose according to a predicted blood glucose trajectory
US11229382B2 (en) 2013-12-31 2022-01-25 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
MX373076B (es) 2014-01-31 2020-07-06 Univ Boston Control de nivel de glucosa fuera de línea basado en periodos anteriores de control de nivel de glucosa en línea.
EP4151150B1 (en) 2014-03-30 2025-08-27 Abbott Diabetes Care Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
AU2015274894B2 (en) 2014-06-10 2018-11-15 Bigfoot Biomedical, Inc. Insulin delivery systems and methods
EP3161730B1 (en) 2014-06-30 2025-05-07 Evolving Machine Intelligence Pty Ltd A system and method for modelling system behaviour
CN104181958B (zh) * 2014-07-22 2016-06-08 南京归图科技发展有限公司 一种过热汽温快速节能预测控制方法
US9983554B2 (en) 2014-11-25 2018-05-29 Mitsubishi Electric Research Laboratories, Inc. Model predictive control with uncertainties
CN111905188B (zh) 2015-02-18 2022-07-22 英赛罗公司 流体输送和输注装置及其使用方法
US9878097B2 (en) 2015-04-29 2018-01-30 Bigfoot Biomedical, Inc. Operating an infusion pump system
AU2016260547B2 (en) 2015-05-14 2020-09-03 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US10064994B2 (en) 2015-05-22 2018-09-04 Iowa State University Research Foundation, Inc. Automatic insulin delivery system
US10281897B2 (en) 2015-06-02 2019-05-07 Mitsubishi Electric Research Laboratories, Inc. Model predictive control with uncertainties
JP6986007B2 (ja) 2015-07-10 2021-12-22 アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. 生理学的パラメータに対する動的グルコースプロファイル応答のシステム、デバイス及び方法
DK3319511T3 (da) 2015-08-07 2021-11-01 Univ Boston Glucosestyringssystem med automatisk tilpasning af glucosemål
US10449294B1 (en) 2016-01-05 2019-10-22 Bigfoot Biomedical, Inc. Operating an infusion pump system
JP2019509770A (ja) 2016-01-05 2019-04-11 ビッグフット バイオメディカル インコーポレイテッドＢｉｇｆｏｏｔ Ｂｉｏｍｅｄｉｃａｌ， Ｉｎｃ． 動作するマルチモーダル薬剤デリバリ・システム
WO2017123805A1 (en) * 2016-01-12 2017-07-20 President And Fellows Of Harvard College Predictive control model for the artificial pancreas using past predictions
US10275573B2 (en) 2016-01-13 2019-04-30 Bigfoot Biomedical, Inc. User interface for diabetes management system
HK1256995A1 (zh) 2016-01-14 2019-10-11 Bigfoot Biomedical, Inc. 药物输送设备、系统和方法中的阻塞解决方案
US10806859B2 (en) 2016-01-14 2020-10-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
US11167081B2 (en) 2016-06-16 2021-11-09 Smiths Medical Asd, Inc. Assemblies and methods for infusion pump system administration sets
WO2018009614A1 (en) 2016-07-06 2018-01-11 President And Fellows Of Harvard College Event-triggered model predictive control for embedded artificial pancreas systems
WO2018058041A1 (en) 2016-09-23 2018-03-29 Insulet Corporation Fluid delivery device with sensor
US10792421B2 (en) 2016-10-05 2020-10-06 Iowa State University Research Foundation, Inc. Automatic insulin delivery system with minimized input variable lag
CA3037432A1 (en) 2016-12-12 2018-06-21 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP3568860B1 (en) 2017-01-13 2025-12-10 Insulet Corporation Insulin delivery methods, systems and devices
US10881793B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP4708311A2 (en) 2017-01-13 2026-03-11 Insulet Corporation Insulin delivery methods, systems and devices
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
CA3050721A1 (en) 2017-01-23 2018-07-26 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
EP4621804A3 (en) 2017-03-21 2025-12-10 Abbott Diabetes Care, Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
US11497851B2 (en) 2017-03-31 2022-11-15 Lifescan Ip Holdings, Llc Maintaining maximum dosing limits for closed loop insulin management systems
CA3198598A1 (en) * 2017-05-05 2018-11-08 Eli Lilly And Company Closed loop control of physiological glucose
US12161463B2 (en) 2017-06-09 2024-12-10 President And Fellows Of Harvard College Prevention of post-bariatric hypoglycemia using a novel glucose prediction algorithm and mini-dose stable glucagon
WO2019018658A2 (en) 2017-07-19 2019-01-24 Smiths Medical Asd, Inc. PENCIL ARRANGEMENTS FOR INFUSION PUMPS
EP3438858A1 (en) * 2017-08-02 2019-02-06 Diabeloop Closed-loop blood glucose control systems and methods
DK3928687T3 (da) 2017-10-24 2024-09-30 Dexcom Inc Bærbar indretning med på forhånd forbundet analytsensor
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
WO2019090016A1 (en) * 2017-11-02 2019-05-09 Boston Scientific Scimed, Inc. Systems and methods for graded glucose control
WO2019090009A1 (en) 2017-11-02 2019-05-09 Boston Scientific Scimed, Inc. System and method for providing glucose control therapy
WO2019125932A1 (en) 2017-12-21 2019-06-27 Eli Lilly And Company Closed loop control of physiological glucose
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
EP3788628B1 (en) 2018-05-04 2024-12-11 Insulet Corporation Safety constraints for a control algorithm-based drug delivery system
US12562251B1 (en) 2018-05-09 2026-02-24 Bigfoot Biomedical, Inc. Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices
US12128212B2 (en) 2018-06-19 2024-10-29 President And Fellows Of Harvard College Adaptive zone model predictive control with a glucose and velocity dependent dynamic cost function for an artificial pancreas
CN112313754A (zh) 2018-06-22 2021-02-02 伊莱利利公司 胰岛素和普兰林肽输送系统、方法和设备
US11147922B2 (en) 2018-07-13 2021-10-19 Iowa State University Research Foundation, Inc. Feedback predictive control approach for processes with time delay in the manipulated variable
MA53724A (fr) * 2018-09-24 2021-12-29 Amgen Inc Systèmes et procédés de dosage interventionnel
US11628251B2 (en) 2018-09-28 2023-04-18 Insulet Corporation Activity mode for artificial pancreas system
EP3864668A1 (en) 2018-10-11 2021-08-18 Insulet Corporation Event detection for drug delivery system
DE102018009902A1 (de) * 2018-12-20 2020-06-25 B. Braun Melsungen Ag Verfahren und Vorrichtung zur Erstellung eines kontinuierlichen Verlaufs und zur Vorhersage der Fluidbilanz eines Patienten
CN113195022A (zh) 2018-12-21 2021-07-30 雅培糖尿病护理公司 用于分析物传感器插入的系统、装置和方法
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
US11464908B2 (en) 2019-02-18 2022-10-11 Tandem Diabetes Care, Inc. Methods and apparatus for monitoring infusion sites for ambulatory infusion pumps
US20220189632A1 (en) * 2019-03-15 2022-06-16 3M Innovative Properties Company Individualized medicine using causal models
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation
MX2022000670A (es) 2019-07-16 2022-05-20 Beta Bionics Inc Sistema de control de glucosa en sangre.
DE112020003406T5 (de) 2019-07-16 2022-06-23 Beta Bionics, Inc. Blutzuckerkontrollsystem
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
JP7607291B2 (ja) 2019-10-04 2024-12-27 ベータ バイオニクス，インコーポレイテッド 血中グルコース制御システム
WO2021113647A1 (en) 2019-12-06 2021-06-10 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
JP7512395B2 (ja) 2020-01-06 2024-07-08 インスレット コーポレイション 持続する残差に基づく食事および／または運動行為の予測
WO2022140204A1 (en) 2020-12-21 2022-06-30 Beta Bionics, Inc. Medicament pumps and control systems thereof
US12370307B2 (en) 2020-02-03 2025-07-29 Insulet Corporation Use of fuzzy logic in predicting user behavior affecting blood glucose concentration in a closed loop control system of an automated insulin delivery device
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US12495994B2 (en) 2020-02-20 2025-12-16 Insulet Corporation Meal bolus subcategories in model based insulin therapy
KR102495891B1 (ko) * 2020-03-04 2023-02-06 이오플로우(주) 약액 제어 주입 디바이스
US11278661B2 (en) 2020-03-10 2022-03-22 Beta Bionics, Inc. Infusion system and components thereof
WO2021183611A1 (en) * 2020-03-10 2021-09-16 Trustees Of Boston University Integrated user-defined input into a closed-loop glucose control system
USD1032624S1 (en) 2020-03-10 2024-06-25 Beta Bionics, Inc. Display screen with animated graphical user interface
USD1032623S1 (en) 2020-03-10 2024-06-25 Beta Bionics, Inc. Display screen with animated graphical user interface
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US11911595B2 (en) 2020-05-18 2024-02-27 Tandem Diabetes Care, Inc. Systems and methods for automated insulin delivery response to meal announcements
WO2022020197A1 (en) 2020-07-22 2022-01-27 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US11951284B2 (en) 2020-08-27 2024-04-09 Tandem Diabetes Care, Inc. Transitioning to other modes in automated insulin delivery
CA3188510A1 (en) 2020-08-31 2022-03-03 Vivek S. RAO Systems, devices, and methods for analyte sensor insertion
US12569168B2 (en) 2020-09-15 2026-03-10 Abbott Diabetes Care Inc. Systems, devices, and methods for analyte monitoring
US12569619B2 (en) 2020-09-21 2026-03-10 Insulet Corporation Techniques for determining automated insulin delivery dosages
EP4221588A1 (en) 2020-09-30 2023-08-09 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
WO2022072332A1 (en) 2020-09-30 2022-04-07 Insulet Corporation Drug delivery device with integrated optical-based glucose monitor
US20220199218A1 (en) 2020-12-07 2022-06-23 Beta Bionics, Inc. Ambulatory medicament pump with integrated medicament ordering interface
US20220265143A1 (en) 2020-12-07 2022-08-25 Beta Bionics, Inc. Ambulatory medicament pumps with selective alarm muting
US11610661B2 (en) 2020-12-07 2023-03-21 Beta Bionics, Inc. Ambulatory medicament pump with safe access control
US11497852B2 (en) 2020-12-21 2022-11-15 Beta Bionics, Inc. Ambulatory medicament device with power saving mode
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
EP4305636A1 (en) 2021-03-10 2024-01-17 Insulet Corporation A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
US12465686B2 (en) 2021-03-25 2025-11-11 Beta Bionics, Inc. Emergency medicament dose control
WO2022204705A1 (en) * 2021-03-25 2022-09-29 Beta Bionics, Inc. Emergency medicament dose control
US12592306B2 (en) 2021-04-28 2026-03-31 Insulet Corporation Devices and methods for initialization of drug delivery devices using measured analyte sensor information
US12496398B2 (en) 2021-05-28 2025-12-16 Insulet Corporation Threshold based automatic glucose control response
US12406760B2 (en) 2021-06-07 2025-09-02 Insulet Corporation Exercise safety prediction based on physiological conditions
US12514980B2 (en) 2021-06-30 2026-01-06 Insulet Corporation Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase
US12521486B2 (en) 2021-07-16 2026-01-13 Insulet Corporation Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems
WO2023049900A1 (en) 2021-09-27 2023-03-30 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
EP4243030A1 (en) 2022-03-09 2023-09-13 Insulet Corporation Adjusting medicament delivery parameters in an open loop medicament delivery mode
CN120457493A (zh) 2023-01-06 2025-08-08 英赛罗公司 自动或手动启动的随餐推注输送及随后的自动安全约束放宽

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280494A (en) * 1979-06-26 1981-07-28 Cosgrove Robert J Jun System for automatic feedback-controlled administration of drugs
GB8615662D0 (en) 1986-06-26 1986-07-30 Exxon Chemical Patents Inc Polymers
EP0374140A4 (en) * 1987-08-28 1990-06-27 Univ Minnesota METABOLIC SENSOR FOR DRUG ADMINISTRATION.
US6554798B1 (en) * 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6669663B1 (en) * 1999-04-30 2003-12-30 Medtronic, Inc. Closed loop medicament pump
JP2003521972A (ja) * 1999-09-24 2003-07-22 ヘルセテック インコーポレイテッド 生理学的監視装置およびこれと関連する計算・表示・通信装置
US6925393B1 (en) * 1999-11-18 2005-08-02 Roche Diagnostics Gmbh System for the extrapolation of glucose concentration
DE10006044A1 (de) * 2000-02-10 2001-08-16 Roche Diagnostics Gmbh Anordnung und Verfahren zur Dosierung eines die Blutglukose eines Patienten regulierenden Hormons
AU2001292946A1 (en) * 2000-09-26 2002-04-08 Advantage 3D Llc Method and system for generation, storage and distribution of omni-directional object views
US20030073609A1 (en) * 2001-06-29 2003-04-17 Pinkerton Thomas C. Enhanced pharmacokinetic profile of intradermally delivered substances
US20030208113A1 (en) * 2001-07-18 2003-11-06 Mault James R Closed loop glycemic index system
US6544212B2 (en) * 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
GB0206792D0 (en) * 2002-03-22 2002-05-01 Leuven K U Res & Dev Normoglycemia
US20040010207A1 (en) * 2002-07-15 2004-01-15 Flaherty J. Christopher Self-contained, automatic transcutaneous physiologic sensing system
US9872890B2 (en) * 2003-03-19 2018-01-23 Paul C. Davidson Determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients
WO2006124716A2 (en) * 2005-05-13 2006-11-23 Trustees Of Boston University Fully automated control system for type 1 diabetes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010531678A (ja) * 2007-06-21 2010-09-30 ユニバーシティ オブ バージニア パテント ファウンデーション Ｌｑｇ人工膵臓制御システム及び関連方法

Also Published As

Publication number Publication date
JP5389147B2 (ja) 2014-01-15
US20080208113A1 (en) 2008-08-28
WO2006124716A3 (en) 2007-03-08
WO2006124716A2 (en) 2006-11-23
US8273052B2 (en) 2012-09-25
US7806854B2 (en) 2010-10-05
JP2008545454A (ja) 2008-12-18
US20110106049A1 (en) 2011-05-05
JP2012086032A (ja) 2012-05-10
EP1881786B1 (en) 2017-11-15
CA2612714A1 (en) 2006-11-23
CA2612714C (en) 2013-09-24
EP1881786A4 (en) 2009-05-27
EP1881786A2 (en) 2008-01-30

Similar Documents

Publication Publication Date Title
JP5037496B2 (ja) １型糖尿病用の完全自動制御システム
US12380981B2 (en) Closed loop control of physiological glucose
US12539365B2 (en) System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy
JP7488293B2 (ja) グルコース目標の自動適合を備えたグルコース制御システム
CN106456064B (zh) 基于在前时期的离线葡萄糖控制
CA3071570C (en) Closed-loop blood glucose control systems and methods
KR102556582B1 (ko) 환자의 혈당치 조절용 자동화 시스템
JP2019528913A (ja) 患者の血糖値を制御するための自動システム
KR102398748B1 (ko) 환자의 혈당 조절용 자동 시스템
JP2004502474A (ja) 患者の血中グルコースを調節するホルモンを適量投与するための装置および方法
CN116762136A (zh) 基于风险的胰岛素输送转换的系统和方法
JP7424996B2 (ja) 患者の血糖値をモニタするための自動システム
US9827371B2 (en) Method for controlling the delivery of insulin and the related system
US20230218821A1 (en) Tdd tracking approaches for insulin delivery systems, methods, and devices

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090716

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100916

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100922

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101215

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101222

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110117

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110124

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110208

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110216

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110928

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111216

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120619

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120704

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150713

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5037496

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250